Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase

Published:2023-10 Issue: Volume:218 Page:105716
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bennett Ryan P.,Yoluç Yasemin,Salter Jason D.,Ripp Alexander^ORCID,Jessen Henning J.^ORCID,Kaiser Stefanie M.^ORCID,Smith Harold C.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference45 articles.

1. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses;Agnihothram;J. Infect. Dis.,2014

2. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection;Arabi;Ann. Intern. Med.,2014

3. A novel Ebola virus VP40 matrix protein-based screening for identification of novel candidate medical countermeasures;Bennett;Viruses,2020

4. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties;Bennett;JCI Insight,2022

5. Trimmomatic: a flexible trimmer for Illumina sequence data;Bolger;Bioinformatics,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry;Nucleosides, Nucleotides & Nucleic Acids;2024-05-13

2. Intracellular delivery and deep tissue penetration of nucleoside triphosphates using photocleavable covalently bound dendritic polycations;Chemical Science;2024

3. Corrigendum to “Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase” [Antivir. Res. 218 (2023) 105716–105728, doi: 10.1016/j.antiviral.2023.105716];Antiviral Research;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3